In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Cardiovascular risk
Bad news for young men with T2D
- Uncategorized
- Case Report
6-year-old child with central retinal artery occlusion
- Low grade serous ovarian carcinoma (LGSOC)
Opening up new horizons through combination therapies
- Rare diseases
Yellow nail and Swyer-James syndrome
- Results of a systematic review and meta-analysis
Physical activity as a therapeutic approach for depression and anxiety disorders
- Underestimated risk - findings from a US cohort
Heart failure after myocardial infarction
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- From symptom to diagnosis